Møllersen Kajsa, Kirchesch Herbert, Zortea Maciel, Schopf Thomas R, Hindberg Kristian, Godtliebsen Fred
Norwegian Centre for Integrated Care and Telemedicine, University Hospital of North Norway, 9038 Tromsø, Norway.
Private Office, Venloer Straße 107, 50259 Pulheim, Germany.
Biomed Res Int. 2015;2015:579282. doi: 10.1155/2015/579282. Epub 2015 Nov 26.
Commercially available clinical decision support systems (CDSSs) for skin cancer have been designed for the detection of melanoma only. Correct use of the systems requires expert knowledge, hampering their utility for nonexperts. Furthermore, there are no systems to detect other common skin cancer types, that is, nonmelanoma skin cancer (NMSC). As early diagnosis of skin cancer is essential, there is a need for a CDSS that is applicable to all types of skin lesions and is suitable for nonexperts. Nevus Doctor (ND) is a CDSS being developed by the authors. We here investigate ND's ability to detect both melanoma and NMSC and the opportunities for improvement. An independent test set of dermoscopic images of 870 skin lesions, including 44 melanomas and 101 NMSCs, were analysed by ND. Its sensitivity to melanoma and NMSC was compared to that of Mole Expert (ME), a commercially available CDSS, using the same set of lesions. ND and ME had similar sensitivity to melanoma. For ND at 95% melanoma sensitivity, the NMSC sensitivity was 100%, and the specificity was 12%. The melanomas misclassified by ND at 95% sensitivity were correctly classified by ME, and vice versa. ND is able to detect NMSC without sacrificing melanoma sensitivity.
市面上现有的用于皮肤癌的临床决策支持系统(CDSS)仅设计用于检测黑色素瘤。正确使用这些系统需要专业知识,这限制了它们对非专业人员的实用性。此外,目前还没有用于检测其他常见皮肤癌类型,即非黑色素瘤皮肤癌(NMSC)的系统。由于皮肤癌的早期诊断至关重要,因此需要一种适用于所有类型皮肤病变且适合非专业人员的CDSS。痣博士(ND)是作者正在开发的一种CDSS。我们在此研究ND检测黑色素瘤和NMSC的能力以及改进的机会。ND分析了一个包含870个皮肤病变的皮肤镜图像独立测试集,其中包括44个黑色素瘤和101个NMSC。使用同一组病变,将其对黑色素瘤和NMSC的敏感性与市售CDSS痣专家(ME)的敏感性进行了比较。ND和ME对黑色素瘤的敏感性相似。对于敏感性为95%的ND,其对NMSC的敏感性为100%,特异性为12%。ND在95%敏感性下误分类的黑色素瘤被ME正确分类,反之亦然。ND能够在不牺牲黑色素瘤敏感性的情况下检测NMSC。